Zydus Lifesciences informs about press release

20 Apr 2023 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated April 20, 2023 titled ‘Zydus receives final approval from the USFDA for Metoprolol Tartrate Tablets USP, 25 mg, 50 mg, and 100 mg’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

906.15 -3.85 (-0.42%)
17-Feb-2026 13:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.15
Dr. Reddys Lab 1277.80
Cipla 1342.70
Zydus Lifesciences 906.15
Lupin 2240.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×